9 news items
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
TAK
9 May 24
values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
TAK
26 Apr 24
and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
TAK
22 Apr 24
to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
TAK
18 Apr 24
headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
TAK
26 Mar 24
values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet
2juo75i7qb1a7br2643p22ay7jfccxz4yp8team7my0k2cvw62ic237m4
TAK
13 Mar 24
-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees
ofqwoan 4aqr9
TAK
26 Feb 24
and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us
paisoy48l77xmn0kea2tetqvn8pxqd7ibbyaovial7c1irqbw
TAK
26 Feb 24
-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology
jjz00un7mlrs3xxkka1jol9dts2qk3dlu84gokoq
TAK
13 Feb 24
to discovering and delivering life-transforming treatments, guided by our commitment to patients, our people, and the planet. Takeda focuses its R&D
- Prev
- 1
- Next